India may get a fourth Covid-19 vaccine by August, a govt official said

India is hoping to get Hyderabad-based Biological E native Covid-19 vaccine by August this year. Biological E Ltd is done with phase 1 and phase 2 trials. Now, they are ready for phase 3 routes.

“The trials of phase 1, phase 2 of the Indian Biological E vaccine have finished and will go to phase 3. This is a very significant development as they have capacity for 7 crore / 70 million vaccines a month,” member NITI Aayog Dr VK Paul said today.

Biological E Ltd will produce 1 billion doses of Covid-19 vaccines including the one developed by Johnson & Johnson under the Quad Vaccine Partnership, a White House press release said earlier.

“The United States, through the DFC (Development Finance Corporation), will work with Biological E Ltd, to fund increased capacity to support Biological E’s effort to produce at least 1 billion doses of Covid-19 vaccines by the end of 2022 with Regulation Authorization String (SRA) and / or World Health Organization (WHO) Emergency Use List, including Johnson & Johnson vaccine, ”the statement said.

Together with the Serum Institute and Bharat Biotech, the company has been one of the most active vaccine developers from India during the pandemic, developing a protein sub-protein vaccine developed by Baylor College of Medicine in the US and manufacturing mass of another by Johnson & Johnson.

Biological E Ltd is the largest manufacturer of tetanus vaccines and snake venom antioxidants in India.

More Covid vaccines on the way

  • Zydus Cadila of Gujarat; the second indigenous vaccine is expected by August.
  • Novavax American Company, to which the Indian Serum Institute has affiliated; the second SII vaccine can be introduced in India by September.
  • Bharat Biotech, the company’s second intranasal shotgun vaccine; is likely to be available by October.

Currently, India has granted Urgent Use Authorization to three vaccine candidates – indigenous manufactured vaccines (Indian Serum Institute and Bharat Biotech), and a third vaccine (Sputnik) which, although manufactured abroad at present, is finally being manufactured in India.

Subscribe to Mint Newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.